You just read:

New Evidence from Large Studies Highlights Value of Oncotype DX Breast Recurrence Score® to Guide Chemotherapy Treatment in Young Patients with Node-negative or Node-positive Early-stage Breast Cancer

News provided by

EXACT SCIENCES CORP

Dec 12, 2019, 06:00 ET